CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203857670
- Phone
- 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $382,086
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$382,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Hamilton Thomas Edward Director | Purchase | +70,000 | $2.67 | $187K | 70,000 |
| 2026-11-11 | BEN-MAIMON CAROLE President and CEO | Purchase | +18,050 | $2.77 | $50K | 386,326 |
| 2026-11-11 | THOMAS FRANK E Director | Purchase | +8,000 | $2.73 | $22K | 15,000 |
| 2026-11-11 | Truitt Joseph Director | Purchase | +3,500 | $2.80 | $10K | 6,250 |
| 2026-11-11 | Harlow John B. Jr. President and COO | Purchase | +17,800 | $2.80 | $50K | 67,800 |
| 2026-11-11 | Celano Michael Chief Financial Officer | Purchase | +18,460 | $2.71 | $50K | 234,245 |
| 2026-11-11 | Shankar Gopi Chief Development Officer | Purchase | +5,000 | $2.71 | $14K | 81,443 |
Page 1 of 1 · 7 trades